Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'GRAFT-VERSUS-LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 267 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rivas, C; Miller, ARM; Collado, M; Lam, EWF; Apperley, JF; Melo, JV
      BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

      MOLECULAR THERAPY
    2. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    3. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    4. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    5. Maris, M; Sandmaier, BM; Maloney, DG; McSweeney, PA; Woolfrey, A; Chauncey, T; Shizuru, J; Niederwieser, D; Blume, KG; Forman, S; Storb, R
      Non-myeloablative hematopoietic stem cell transplantation

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    6. Lamana, ML; Segovia, JC; Guenechea, G; Bueren, JA
      Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells

      JOURNAL OF GENE MEDICINE
    7. Maris, M; Woolfrey, A; McSweeney, PA; Sandmaier, BM; Nash, RA; Georges, G; Maloney, DG; Molina, A; Chauncey, T; Yu, C; Zaucha, JM; Blume, KG; Shizuru, J; Niederwieser, D; Storb, R
      Nonmyeloablative hematopoietic stem cell transplantation: Transplantation for the 21(st) century

      FRONTIERS IN BIOSCIENCE
    8. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    9. Johnson, BD; Dagher, N; Stankowski, MC; Hanke, CA; Truitt, RL
      Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    10. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    11. Gorschluter, M; Ziske, C; Glasmacher, A; Schmidt-Wolf, IGH
      Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma

      CLINICAL CANCER RESEARCH
    12. Paquin, A; Jaalouk, DE; Galipeau, J
      Retrovector encoding a green fluorescent protein-herpes simplex virus thymidine kinase fusion protein serves as a versatile suicide/reporter for celland gene therapy applications

      HUMAN GENE THERAPY
    13. Childs, RW
      Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma

      CRITICAL REVIEWS IN IMMUNOLOGY
    14. O'Neill, MM; Kennedy, CA; Barton, RW; Tatake, RJ
      Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine

      GENE THERAPY
    15. Sato, T; Ando, K; Oki, M; Miyatake, H; Matsuzawa, H; Hotta, T; Kato, S
      Acute lethal injury of lung and liver in mice transplanted with ex vivo-expanded CTLs

      CELL TRANSPLANTATION
    16. Wurth, C; Kessler, U; Vogt, J; Schulz, GE; Folkers, G; Scapozza, L
      The effect of substrate binding on the conformation and structural stability of Herpes simplex virus type 1 thymidine kinase

      PROTEIN SCIENCE
    17. Brenner, MK
      Gene transfer and the treatment of haematological malignancy

      JOURNAL OF INTERNAL MEDICINE
    18. Alessandrino, EP; Bernasconi, P; Colombo, AA; Caldera, D; Bonfichi, M; Pagnucco, G; Malcovati, L; Varettoni, M; Lazzarino, M; Bernasconi, C
      Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant

      ANNALS OF HEMATOLOGY
    19. Dreger, P; Schmitz, N
      Allogeneic transplantation of blood stem cells: Coming of age?

      ANNALS OF HEMATOLOGY
    20. Vindelov, L
      Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

      EUROPEAN JOURNAL OF HAEMATOLOGY
    21. Garderet, L; Bittencourt, H; Kaliski, A; Daniel, MT; Ribaud, P; Socie, G; Gluckman, E
      Treatment of T-prolymphocytic leukemia with nonmyeloablative allogeneic stem cell transplantation

      EUROPEAN JOURNAL OF HAEMATOLOGY
    22. Queiroz, MLS; Justo, GZ; Valadares, MC; Pereira-da-Silva, FRR; Muller, AH
      Adjuvant effect of Pluchea quitoc extract on the resistance of tumor-bearing mice by modulation of the host hematopoietic response

      IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
    23. Brunstein, CG; McGlave, PB
      The biology and treatment of chronic myelogenous leukemia

      ONCOLOGY-NEW YORK
    24. Martin, TG; Gajewski, JL
      Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    25. van Besien, K; Keralavarma, B; Devine, S; Stock, W
      Allogeneic and autologous transplantation for chronic lymphocytic leukemia

      LEUKEMIA
    26. Schaap, N; Schattenberg, A; Bar, B; Preijers, F; van Kemenade, EV; de Witte, T
      Induction of graft-versus-leukemia to prevent relapse after partially lymphocyte-depleted allogeneic bone marrow transplantation by pre-emptive donorleukocyte infusions

      LEUKEMIA
    27. Garban, F; Attal, M; Rossi, JF; Payen, C; Fegueux, N; Sotto, JJ
      Immunotherapy by non-myeloablative allogeneic stem cell transplantation inmultiple myeloma: results of a pilot study as salvage therapy after autologous transplantation

      LEUKEMIA
    28. Woiciechowsky, A; Regn, S; Kolb, HJ; Roskrow, M
      Leukemic dendritic cells generated in the presence of FLT3 ligand have thecapacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia

      LEUKEMIA
    29. Korbling, M; Giralt, S; Khouri, I; Mirza, N; Donato, M; Anderlini, P; Fischer, H; Andreeff, M; McMannis, J; Champlin, R
      Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis

      JOURNAL OF CLINICAL APHERESIS
    30. Michallet, M; Bilger, K; Garban, F; Attal, M; Huyn, A; Blaise, D; Milpied, N; Moreau, P; Bordigoni, P; Kuentz, M; Sadoun, A; Cahn, JY; Socie, G; Thomas, X; Arnaud, P; Raus, N; Lheritier, V; Pigneux, A; Boiron, JM
      Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: Impact of pretransplantation and posttransplantation factors on outcome

      JOURNAL OF CLINICAL ONCOLOGY
    31. Manna, A; Magli, T
      Extramedullary relapse of acute lymphoblastic leukemia in the breast afterallogeneic stem cell transplantation and concomitant persistence of donor hematopoiesis

      HAEMATOLOGICA
    32. Matsubara, H; Makimoto, A; Takayama, J; Higa, T; Saito, T; Kanda, Y; Tanosaki, R; Mineishi, S; Ohira, M; Takaue, Y
      Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    33. Slavin, S; Or, R; Aker, M; Shapira, MY; Panigrahi, S; Symeonidis, A; Cividalli, G; Nagler, A
      Nonmyeloablative stem cell transplantation for the treatment of cancer andlife-threatening nonmalignant disorders: past accomplishments and future goals

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    34. Burt, RK; Barr, W; Oyama, Y; Traynor, A; Slavin, S
      Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis

      JOURNAL OF RHEUMATOLOGY
    35. Hennessy, BJ; Orchard, KH; Potter, MN
      Novel approaches to transplant conditioning

      HEMATOLOGICAL ONCOLOGY
    36. Slavin, S; Ackerstein, A; Morecki, S; Gelfand, Y; Cividalli, G
      Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes

      BONE MARROW TRANSPLANTATION
    37. Devine, SM; Sanborn, R; Jessop, E; Stock, W; Huml, M; Peace, D; Wickrema, A; Yassine, M; Amin, K; Thomason, D; Chen, YH; Devine, H; Maningo, M; van Besien, K
      Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem celltransplant

      BONE MARROW TRANSPLANTATION
    38. Cwynarski, K; Goulding, R; Pocock, C; Dazzi, F; Craddock, C; Kaeda, J; Olavarria, E; Kanfer, E; Apperley, J; Lawler, M; Goldman, JM
      Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions

      BONE MARROW TRANSPLANTATION
    39. Morecki, S; Gelfand, Y; Nagler, A; Or, R; Naparstek, E; Varadi, G; Engelhard, D; Akerstein, A; Slavin, S
      Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

      BONE MARROW TRANSPLANTATION
    40. Lamb, LS; Musk, P; Ye, Z; van Rhee, F; Geier, SS; Tong, JJ; King, KM; Henslee-Downey, PJ
      Human gamma delta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response

      BONE MARROW TRANSPLANTATION
    41. Dolstra, H; Fredrix, H; van der Meer, A; de Witte, T; Figdor, C; van de Wiel-van Kemenade, E
      Immunobiology - TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells

      BONE MARROW TRANSPLANTATION
    42. Saito, T; Mineishi, S
      Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives

      EXPERIMENTAL ONCOLOGY
    43. Lee, JH; Lee, KH; Kim, S; Seol, M; Kim, SH; Kim, WK; Lee, JS
      Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plusetoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation

      LEUKEMIA RESEARCH
    44. Hui, CH; Bardy, P; Hughes, T; Horvath, N; To, LB
      Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases

      CLINICAL AND LABORATORY HAEMATOLOGY
    45. Milojkovic, D; Mufti, GJ
      Extending the role of allogeneic stem-cell transplantation

      LANCET
    46. Iuliucci, JD; Oliver, SD; Morley, S; Ward, C; Ward, J; Dalgarno, D; Clackson, T; Berger, HJ
      Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903,in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    47. Zorn, E; Orsini, E; Wu, CJ; Stein, B; Chillemi, A; Canning, C; Alyea, EP; Soiffer, RJ; Ritz, J
      A CD4+T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells

      TRANSPLANTATION
    48. Stone, RM
      Postremission therapy in adults with acute myeloid leukemia

      SEMINARS IN HEMATOLOGY
    49. Yang, XF; Wu, CJ; McLaughlin, S; Chillemi, A; Wang, KS; Canning, C; Alyea, EP; Kantoff, P; Soiffer, RJ; Dranoff, G; Ritz, J
      CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    50. Kolb, HJ; Mischak-Weissinger, E
      Cell therapy for hematological neoplasias

      INTERNIST
    51. Weissinger, F; Sandmaier, BM; Maloney, DG; Bensinger, WI; Gooley, T; Storb, R
      Decreased transfusion requirements for patients receiving nonmyeloablativecompared with conventional peripheral blood stem cell transplants from HLA-identical siblings

      BLOOD
    52. Neff, T; Blau, CA
      Pharmacologically regulated cell therapy - Introduction

      BLOOD
    53. Garin, MI; Garrett, E; Tiberghien, P; Apperley, JF; Chalmers, D; Melo, JV; Ferrand, C
      Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene

      BLOOD
    54. Tanaka, J; Tutumi, Y; Zhang, L; Mori, A; Kahata, K; Toyoshima, N; Ohta, S; Kobayashi, S; Hashino, S; Asaka, M; Imamura, M
      Increased proportion of HLA-class-I-specific natural killer cell receptors(CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation

      ACTA HAEMATOLOGICA
    55. Childs, RW
      Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases

      CANCER JOURNAL
    56. Riddell, SR; Warren, EH; Gavin, MA; Akatsuka, Y; Lewinsohn, D; Mutimer, H; Cooper, L; Topp, MS; Bonini, C; Greenberg, PD
      Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones

      CANCER JOURNAL
    57. Lee, JH; Klein, HG
      From leukocyte reduction to leukocyte transfusion: the immunological effects of transfused leukocytes

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    58. Leshem, B; Vourka-Karussis, U; Slavin, S
      Correlation between enhancement of graft-versus-leukemia effects followingallogeneic bone marrow transplantation by rIL-2 and increased frequency ofcytotoxic T-lymphocyte precursors in murine myeloid leukemia

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    59. Yang, YG
      The role of interleukin-12 and interferon-gamma in GVHD and GVL

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    60. Szlosarek, PW; Dalgleish, AG
      Potential applications of gene therapy in the patient with cancer

      DRUGS & AGING
    61. Patterson, AE; Korngold, R
      Cross-protective murine graft-versus-leukemia responses to phenotypically distinct myeloid leukemia lines

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    62. Orsini, E; Alyea, EP; Chillemi, A; Schlossman, R; McLaughlin, S; Canning, C; Soiffer, RJ; Anderson, KC; Ritz, J
      Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    63. Hsieh, MH; Patterson, AE; Korngold, R
      T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    64. Radich, JP; Gooley, T; Sanders, JE; Anasetti, C; Chauncey, T; Appelbaum, FR
      Second allogeneic transplantation after failure of first autologous transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    65. O'Reilly, RJ
      Clinical trials of hematopoietic cell transplantations: Current needs and future strategies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    66. Uckert, W; Becker, C; Gladow, M; Klein, D; Kammertoens, T; Pedersen, L; Blankenstein, T
      Efficient gene transfer into primary human CD8(+) T lymphocytes by MuLV-10A1 retrovirus pseudotype

      HUMAN GENE THERAPY
    67. Introna, M; Barbui, AM; Bambacioni, F; Casati, C; Gaipa, G; Borleri, G; Bernasconi, S; Barbui, T; Golay, J; Biondi, A; Rambaldi, A
      Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies

      HUMAN GENE THERAPY
    68. Hiller, C; Wittmann, S; Slavin, S; Fickenscher, H
      Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector

      GENE THERAPY
    69. Schleuning, M
      Adoptive allogeneic immunotherapy - history and future perspectives

      TRANSFUSION SCIENCE
    70. Slavin, S
      New strategies for bone marrow transplantation

      CURRENT OPINION IN IMMUNOLOGY
    71. Hehlmann, R; Hochhaus, A; Berger, U; Reiter, A
      Current trends in the management of chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    72. Di Ianni, M; Di Florio, S; Venditti, G; Liberatore, C; Lucheroni, F; Falzetti, F; Terenzi, A; Stella, CC; Spinozzi, F; Mannoni, P; Martelli, MF; Tabilio, A
      T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection

      CANCER GENE THERAPY
    73. Rivas, C; Chandler, P; Melo, JV; Simpson, E; Apperley, JF
      Absence of in vitro or in vivo bystander effects in a thymidine kinase-transduced murine T lymphoma

      CANCER GENE THERAPY
    74. Fujii, N; Maeda, Y; Takenaka, K; Shinagawa, K; Imai, T; Kozuka, T; Ikeda, K; Sunami, K; Hiramatsu, Y; Ishimaru, F; Niiya, K; Harada, M
      Successful engraftment of allogeneic peripheral blood stem cell transplantafter nonmyeloablative preparative regimen with cytarabine and cyclophosphamide: Report of 2 cases

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    75. Takenaka, K; Shinagawa, K; Sunami, K; Fujii, N; Hiramatsu, Y; Maeda, Y; Nawa, Y; Katayama, Y; Teshima, T; Ishimaru, F; Kiura, K; Ikeda, K; Harada, M
      Allogeneic peripheral blood stem cell transplantation in 23 adult patientswith hematologic malignancies: A single-center experience

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    76. Murata, M; Emi, N; Hirabayashi, N; Hamaguchi, M; Goto, S; Wakita, A; Tanimoto, M; Saito, H; Kodera, Y; Morishita, Y
      No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    77. Sao, H; Kato, C; Kitaori, K; Adachi, T; Yano, K; Kobayashi, M; Kojima, H; Tanimoto, M; Hirabayashi, N; Minami, S; Yamada, H; Morishita, Y; Morishima, Y; Kodera, Y
      Effective and safe interferon treatment for Japanese patients with chronicmyelogenous leukemia relapse after bone marrow transplantation

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    78. Ashida, T; Kawanishi, K; Ariyama, T; Hamasaki, H; Maeda, Y; Tsubaki, K; Kanamaru, A
      Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    79. Burdach, S; van Kaick, B; Laws, HJ; Ahrens, S; Haase, R; Korholz, D; Pape, H; Dunst, J; Kahn, T; Willers, R; Engel, B; Dirksen, U; Kramm, C; Nurnberger, W; Heyll, A; Ladenstein, R; Gadner, H; Jurgens, H; Gobel, U
      Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors - An update after long-term follow-up from two centers of the European Intergroup Study EICESS

      ANNALS OF ONCOLOGY
    80. Toze, CL; Shepherd, JD; Connors, JM; Voss, NJ; Gascoyne, RD; Hogge, DE; Klingemann, HG; Nantel, SH; Nevill, TJ; Phillips, GL; Reece, DE; Sutherland, HJ; Conneally, EA; Barnett, MJ
      Allografting for indolent lymphoid neoplasms

      ANNALS OF ONCOLOGY
    81. Borgmann, A; Baldy, C; Von Stackelberg, A; Beyermann, B; Fichtner, I; Nurnberg, P; Henze, G
      Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    82. Garcia-Castro, J; Segovia, JC; Bueren, JA
      Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice

      LEUKEMIA
    83. Seong, CM; Giralt, S; Kantarjian, H; Xu, JP; Swantkowski, J; Hayes, K; Glassman, AB; Khouri, I; Korbling, M; Thall, P; Siciliano, MJ; Champlin, RE
      Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    84. Lokhorst, HM; Schattenberg, A; Cornelissen, JJ; van Oers, MHJ; Fibbe, W; Russell, I; Van der Donk, NWCJ; Verdonck, LF
      Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: Predictive factors for response and long-term outcome

      JOURNAL OF CLINICAL ONCOLOGY
    85. Roman, J; Alvarez, MA; Torres, A
      Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation

      HAEMATOLOGICA
    86. Hale, GA; Phillips, GL
      Allogeneic stem cell transplantation for the non-Hodgkin's lymphomas and Hodgkin's disease

      CANCER TREATMENT REVIEWS
    87. Veelken, H; Wasch, R; Behringer, D; Bertz, H; Finke, J
      Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

      BONE MARROW TRANSPLANTATION
    88. Imoto, S; Murayama, T; Gomyo, H; Mizuno, I; Sugimoto, T; Nakagawa, T; Koizumi, T
      Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    89. Matthes-Martin, S; Mann, G; Peters, C; Lion, T; Fritsch, G; Haas, OA; Potschger, U; Gadner, H
      Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature

      BONE MARROW TRANSPLANTATION
    90. Yazaki, M; Takahashi, T; Ito, Y; Ito, T; Mori, C; Wada, Y
      Generation of HLA-A2 subtype specific cytotoxic T lymphocytes from cord blood used for cord blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    91. Wasch, R; Reisser, S; Hahn, J; Bertz, H; Engelhardt, M; Kunzmann, R; Veelken, H; Holler, E; Finke, J
      Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan andallogeneic transplantation

      BONE MARROW TRANSPLANTATION
    92. Mohty, M; Faucher, C; Vey, N; Stoppa, AM; Viret, F; Chabbert, I; Chabannon, C; Bouabdallah, R; Ladaique, P; Collet, L; Zandotti, C; Maraninchi, D; Baise, D
      High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

      BONE MARROW TRANSPLANTATION
    93. Tanaka, J; Tutumi, Y; Mori, A; Ohta, S; Kobayashi, S; Asaka, M; Imamura, M
      Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease

      BONE MARROW TRANSPLANTATION
    94. Goldberg, SL; Pecora, AL; Rosenbluth, RJ; Jennis, AA; Preti, RA
      Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines

      BONE MARROW TRANSPLANTATION
    95. Bornhauser, M; Thiede, C; Schuler, U; Platzbecker, U; Freiberg-Richter, J; Helwig, A; Plettig, R; Rollig, C; Naumann, R; Kroschinsky, F; Neubauer, A; Ehninger, G
      Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

      BONE MARROW TRANSPLANTATION
    96. Lee, KH; Lee, JH; Kim, S; Lee, JS; Kim, SH; Kim, WK
      High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    97. Ungkanont, A; Mongkonsritrakoon, W; Jootar, S; Srichaikul, T
      Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen

      BONE MARROW TRANSPLANTATION
    98. Howrey, RP; Martin, PL; Driscoll, T; Szabolcs, P; Kelly, T; Shpall, EJ; Bearman, SI; Slat-Vasquez, V; Rubinstein, P; Stevens, CE; Kurtzberg, J
      Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia

      BONE MARROW TRANSPLANTATION
    99. Pavletic, ZS; Arrowsmith, ER; Bierman, PJ; Goodman, SA; Vose, JM; Tarantolo, SR; Stein, RS; Bociek, G; Greer, JP; Wu, CD; Kollath, JP; Weisenburger, DD; Kessinger, A; Wolff, SN; Armitage, JO; Bishop, MR
      Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

      BONE MARROW TRANSPLANTATION
    100. Carella, AM; Champlin, R; Slavin, S; McSweeney, P; Storb, R
      Mini-allografts: ongoing trials in humans

      BONE MARROW TRANSPLANTATION


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 19:30:42